Comparison Overview

Genetic Engineering & Biotechnology News

VS

Risk & Insurance

Genetic Engineering & Biotechnology News

140 Huguenot St, New Rochelle, New York, 10801, US
Last Update: 2025-11-21
View Profile
Between 750 and 799
http://www.genengnews.com

Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success. GEN’s breadth of editorial coverage is unrivaled, providing exclusive reporting, insight, and analysis across the life sciences – from its five foundational pillars of Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing to a new, expanded focus on the emerging areas of Cancer Research, Infectious Diseases, and Artificial Intelligence. Within these areas, GEN delivers exclusive, high-quality reporting on the latest industry news; insider information on cutting-edge tools and technologies; industry-standard protocols, tutorials, and technical articles; first-looks at emerging industry collaborations and investments; reports from key scientific and industry meetings; and A-Lists, our monthly insight and analysis into the top companies, products, and movers & shakers impacting the industry today.

NAICS: 511
NAICS Definition:
Employees: 296
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Risk & Insurance

720 Providence Rd, Malvern, Pennsylvania, 19355, US
Last Update: 2025-11-26
Between 750 and 799
http://riskandinsurance.com/

Who We Are Risk & Insurance® covers the people, stories and risks that embody the essential functions of risk management and commercial insurance. What We Do Some people think of risk management and commercial insurance as staid and dull. Even some insurance executives believe their industry is inferior to the power of Wall Street or innovation of Silicon Valley. That’s where we come in. We see Risk as the most pervasive challenge facing business leaders. The world is becoming ever more interconnected and developed while the speed of technological innovation increases and societal unrest grows. The result is the proliferation of new risks at an almost incalculable rate, global turmoil caused by regional events and the correlation of previously independent risk categories. Without risk mitigation and transfer, primarily through insurance, our economy and society would not exist as we know it. No other profession and industry is so integral to global commerce or impacted by world events. So what’s not to love? Risk & Insurance® strives to identify emerging risks and mitigation strategies, while covering the fascinating people who drive the industry forward. We obsess about the myriad ways insurance plays a vital role in our economy. Our goal is to not only inform and help our readers succeed in their careers but also to inspire and motivate. To accomplish this goal, our coverage is rooted in a set of defining principles: Insurance is Vital. Risk is Compelling. People Matter Most. Storytelling Applies. Creativity is Essential. Positive Outlook Topics We Cover While our approach and tone are our most important differentiators, we also provide expert coverage of core topics such as property and liability as well as the many specialties that comprise the risk management and commercial insurance universe. In addition, we are well known for covering specialized risks faced by a multitude of industries such as Energy, Transportation, Construction, Health Care, etc.

NAICS: 511
NAICS Definition:
Employees: 35
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/genetic-engineering-&-biotechnology-news.jpeg
Genetic Engineering & Biotechnology News
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/risk-insurance.jpeg
Risk & Insurance
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Genetic Engineering & Biotechnology News
100%
Compliance Rate
0/4 Standards Verified
Risk & Insurance
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Genetic Engineering & Biotechnology News in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Risk & Insurance in 2025.

Incident History — Genetic Engineering & Biotechnology News (X = Date, Y = Severity)

Genetic Engineering & Biotechnology News cyber incidents detection timeline including parent company and subsidiaries

Incident History — Risk & Insurance (X = Date, Y = Severity)

Risk & Insurance cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/genetic-engineering-&-biotechnology-news.jpeg
Genetic Engineering & Biotechnology News
Incidents

No Incident

https://images.rankiteo.com/companyimages/risk-insurance.jpeg
Risk & Insurance
Incidents

No Incident

FAQ

Genetic Engineering & Biotechnology News company demonstrates a stronger AI Cybersecurity Score compared to Risk & Insurance company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Risk & Insurance company has disclosed a higher number of cyber incidents compared to Genetic Engineering & Biotechnology News company.

In the current year, Risk & Insurance company and Genetic Engineering & Biotechnology News company have not reported any cyber incidents.

Neither Risk & Insurance company nor Genetic Engineering & Biotechnology News company has reported experiencing a ransomware attack publicly.

Neither Risk & Insurance company nor Genetic Engineering & Biotechnology News company has reported experiencing a data breach publicly.

Neither Risk & Insurance company nor Genetic Engineering & Biotechnology News company has reported experiencing targeted cyberattacks publicly.

Neither Genetic Engineering & Biotechnology News company nor Risk & Insurance company has reported experiencing or disclosing vulnerabilities publicly.

Neither Genetic Engineering & Biotechnology News nor Risk & Insurance holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Genetic Engineering & Biotechnology News company nor Risk & Insurance company has publicly disclosed detailed information about the number of their subsidiaries.

Genetic Engineering & Biotechnology News company employs more people globally than Risk & Insurance company, reflecting its scale as a Book and Periodical Publishing.

Neither Genetic Engineering & Biotechnology News nor Risk & Insurance holds SOC 2 Type 1 certification.

Neither Genetic Engineering & Biotechnology News nor Risk & Insurance holds SOC 2 Type 2 certification.

Neither Genetic Engineering & Biotechnology News nor Risk & Insurance holds ISO 27001 certification.

Neither Genetic Engineering & Biotechnology News nor Risk & Insurance holds PCI DSS certification.

Neither Genetic Engineering & Biotechnology News nor Risk & Insurance holds HIPAA certification.

Neither Genetic Engineering & Biotechnology News nor Risk & Insurance holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
References
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
References
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Published
Date
2025-11-27
Updated
Date
2025-11-27
References
Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.

Published
Date
2025-11-27
Updated
Date
2025-11-27
References